Speech-Language Pathologists in Louisville, OH Accepting Medicare

9 Speech-Language Pathologists found. Showing 1 - 9

Ryan Holmes, M.A., CCC-SLP, CBIS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 116 S Silver St, Louisville, OH 44641 Phone: 330-962-8725

Nanette Trenta, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7337 Easton St, Louisville, OH 44641 Phone: 330-875-2661

Mrs. Megan Conley, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1731 Opal St, Louisville, OH 44641 Phone: 330-704-1980

Krystin O'leary, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 407 E Main St, Louisville, OH 44641 Phone: 330-875-1666

Patrica Swinehart Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2121 Ashland St, Louisville, OH 44641 Phone: 330-479-8009

Lori Gowins Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2121 Ashland St, Louisville, OH 44641 Phone: 330-479-3440    Fax: 330-875-5368

Ms. Sheryl Joy Huff, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 415 N Nickelplate St, Louisville, OH 44641 Phone: 330-875-1177

Jennifer Bennett, MA, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 415 N Nickelplate St, Louisville, OH 44641 Phone: 330-875-1177

Rebecca B Dixon Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2121 Ashland St, Louisville, OH 44641 Phone: 330-479-3440

News Archive

Cancer-related expenditures increase faster than any other area of health care: JAMA

From 1999 through 2006 the use of diagnostic imaging for Medicare patients with cancer increased, with use of positron emission tomography increasing the most significantly, according to a study in the April 28 issue of JAMA. Imaging costs for these patients also increased, outpacing the rate of increase in total costs among Medicare beneficiaries with cancer.

Zimmer Biomet announces financial results for Q2 2015

Zimmer Biomet Holdings, Inc. today reported financial results for the quarter ended June 30, 2015. The Company reported second quarter net sales of $1.17 billion, a decrease of 1.3% reported and an increase of 5.7% constant currency compared to the second quarter of 2014.

Children with fetal alcohol spectrum disorders show weaker brain activation

In the first study of its kind, Prapti Gautam, PhD, and colleagues from The Saban Research Institute of Children's Hospital Los Angeles found that children with fetal alcohol spectrum disorders (FASD) showed weaker brain activation during specific cognitive tasks than their unaffected counterparts.

HIT interventions promising tools in fight to improve medication adherence, despite paucity of data

A new study that reviews more than four decades of medical journal articles about the impact of health information technology (HIT) and electronic communications on medication adherence concludes that while there is evidence to suggest that simple electronic reminders are an effective and low-cost means to improve adherence, there are few studies that show how HIT can be leveraged to more thoughtfully engage or motivate patients to take medications as prescribed.

Oncolytics opens enrollment in REOLYSIN combination U.S. Phase I colorectal cancer study

Oncolytics Biotech Inc. announced today that a U.S. Phase I study of REOLYSIN® in combination with FOLFIRI (Folinic Acid (leucovorin) + Fluorouracil (5-FU) + Irinotecan) in patients with oxaliplatin refractory/intolerant Kras mutant colorectal cancer (REO 022) is now open to enrollment. The principal investigator is Dr. Sanjay Goel of the Montefiore Medical Center at The Albert Einstein College of Medicine in New York.

Read more Medical News

› Verified 2 days ago